Last reviewed · How we verify

NCT06812143: LOAD

Optimizing Strength Training in Older Adults

Recruiting now NA Last updated 30 July 2025
What this trial tests

NA trial testing Strength training in Aging in 68 participants. Currently enrolling.

Timeline
5 February 2025
Primary endpoint
25 December 2026
25 January 2027

Quick facts

Lead sponsorQueens College, The City University of New York
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment68
Start date5 February 2025
Primary completion25 December 2026
Estimated completion25 January 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Queens College, The City University of New York

Who can join

65 and older, any sex, with Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of the current study is to determine whether lifting lighter loads close to failure improves strength training adaptations and function in older adults. The main questions it aims to answer are: 1. The effect of light loads on physical function 2. The effect of light loads on muscle mass, power, and strength Researchers will compare a light-load, high-repetition program to a standard strength training program. Participants will perform supervised strength training twice per week for 20 weeks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Strength training

Trials testing the same drug.

Other recruiting trials for Aging

Currently open trials in the same condition.

Other Queens College, The City University of New York trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06812143.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing